SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Attention shoppers: Walmart trades at a higher multiple than Apple and Microsoft

Mylo’s “AI wingman” helps reignite a fatigued online dating scene

Gilad Altshuler: Nasdaq will keep climbing as new technologies emerge

Code Blue appoints Shelly Shlomo Brownshtein as VP of Client Experience and Resources

Buzz

Most popular

Daily

Weekly

1

AI won’t replace developers—but it will change who gets hired

2

‘It was through their lies that they became multimillionaires’: Charlie Javice fraud trial opens

3

Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift

4

Tel Aviv real estate reaches new peak at over $45,000 per sqm

5

Yad2 now valued at $420 million as investors line up for potential sale

Rimsa

3 stories about Rimsa

Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa

08.06.20|Sophie Shulman

Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition

מטה חברת טבע תרופות

Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition

28.05.19|Hezi Sternlicht

Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich

Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners